Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review

INTRODUCTION: COVID-19 is an acute respiratory viral infection that threatens people worldwide, including people with rheumatic disease, although it remains unclear to what extent various antirheumatic disease therapies increase susceptibility to complications of viral respiratory infections. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilian, Adam, Chock, Yu Pei, Huang, Irvin J., Graef, Elizabeth R., Upton, Laura A., Khilnani, Aneka, Krupnikova, Sonia D. Silinsky, Almaghlouth, Ibrahim, Cappelli, Laura C., Fernandez-Ruiz, Ruth, Frankel, Brittany A., Frankovich, Jourdan, Harrison, Carly, Kumar, Bharat, Monga, Kanika, Vega, Jorge A. Rosario, Singh, Namrata, Sparks, Jeffrey A., Sullo, Elaine, Young, Kristen J., Duarte-Garcia, Ali, Putman, Michael, Johnson, Sindhu, Grainger, Rebecca, Wallace, Zachary S., Liew, Jean W., Jayatilleke, Aruni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832282/
https://www.ncbi.nlm.nih.gov/pubmed/32931985
http://dx.doi.org/10.1016/j.semarthrit.2020.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832282/
https://www.ncbi.nlm.nih.gov/pubmed/32931985
http://dx.doi.org/10.1016/j.semarthrit.2020.07.007

Ejemplares similares